We are live on
!
Find out more
PCM
Perkins Capital Management Portfolio holdings
AUM
$133M
1-Year Est. Return
127.86%
This Fund
S&P 500
This Quarter
Est. Return
+0.18%
1 Year Est. Return
+127.86%
3 Year Est. Return
+303.11%
5 Year Est. Return
+333.48%
10 Year Est. Return
–
AUM
$89.4M
AUM Growth
-$7.24M
(-7.5%)
Cap. Flow
+$731K
Cap. Flow
% of AUM
0.82%
Top 10 Holdings %
Top 10 Hldgs %
34.76%
Holding
112
New
7
Increased
13
Reduced
63
Closed
8
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
LeMaitre Vascular
LMAT
|
+$1.94M |
| 2 |
TELA Bio
TELA
|
+$1.44M |
| 3 |
VJET
VOXELJET AG American Depositary Shares (each representing one Ordinary Share)
VJET
|
+$648K |
| 4 |
Backblaze
BLZE
|
+$442K |
| 5 |
Ionis Pharmaceuticals
IONS
|
+$270K |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
SMED
Sharps Compliance Corp
SMED
|
+$552K |
| 2 |
AquaBounty Technologies
AQB
|
+$510K |
| 3 |
Digi International
DGII
|
+$199K |
| 4 |
RYM
RYTHM Inc
RYM
|
+$191K |
| 5 |
Lumen
LUMN
|
+$144K |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Healthcare | 57.38% |
| 2 | Technology | 19.83% |
| 3 | Communication Services | 7.23% |
| 4 | Industrials | 7.09% |
| 5 | Consumer Staples | 4.85% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
|
PFIE
26
DELISTED
Profire Energy, Inc
PFIE
| $1.24M | 1.38% |
1,453,515
-100,865
| -6% | -$116K |
|
|
EGIO
27
DELISTED
Edgio, Inc. Common Stock
EGIO
| $1.21M | 1.35% |
10,875
-500
| -4% | -$59.2K |
|
28
Target
TGT
$67.3B
| $1.15M | 1.28% |
7,729
-50
| -0.6% | -$8.01K |
|
29
Bristol-Myers Squibb
BMY
$135B
| $1.11M | 1.24% |
15,641
-867
| -5% | -$62.9K |
|
30
Merck
MRK
$316B
| $1.03M | 1.15% |
11,925
-100
| -0.8% | -$8.93K |
|
31
CareDx
CDNA
$2.44B
| $969K | 1.08% |
56,942
-1,550
| -3% | -$33.3K |
|
|
CTLP
32
DELISTED
Cantaloupe
CTLP
| $923K | 1.03% |
265,350
-4,775
| -2% | -$26.2K |
|
33
Magnite
MGNI
$2.99B
| $894K | 1% |
136,075
+50
| +0% | +$402 |
|
34
Gilead Sciences
GILD
$168B
| $883K | 0.99% |
14,317
-1,300
| -8% | -$82K |
|
|
PDCO
35
DELISTED
Patterson Companies, Inc.
PDCO
| $864K | 0.97% |
35,950
-1,250
| -3% | -$35.8K |
|
36
Vericel Corp
VCEL
$2.37B
| $844K | 0.94% |
36,367
| – | – |
|
37
Castle Biosciences
CSTL
$953M
| $811K | 0.91% |
31,110
-2,060
| -6% | -$57.8K |
|
38
BioLife Solutions
BLFS
$1.59B
| $728K | 0.81% |
32,000
| – | – |
|
39
Ciena
CIEN
$58.2B
| $728K | 0.81% |
18,000
| – | – |
|
40
Achieve Life Sciences
ACHV
$664M
| $720K | 0.81% |
218,100
-10,000
| -4% | -$47.7K |
|
41
Exagen
XGN
$156M
| $698K | 0.78% |
257,455
+20,480
| +9% | +$114K |
|
42
Fortress Biotech
FBIO
$90.4M
| $682K | 0.76% |
52,834
+2,101
| +4% | +$31.5K |
|
43
3M
MMM
$93.6B
| $678K | 0.76% |
7,340
-197
| -3% | -$21.6K |
|
44
Perspective Therapeutics
CATX
$342M
| $655K | 0.73% |
285,064
-6,386
| -2% | -$21.8K |
|
|
AUGX
45
DELISTED
Augmedix, Inc. Common Stock
AUGX
| $648K | 0.73% |
446,900
+7,400
| +2% | +$12.7K |
|
46
Apple
AAPL
$4.52T
| $643K | 0.72% |
4,650
| – | – |
|
|
AKTS
47
DELISTED
Akoustis Technologies Inc
AKTS
| $643K | 0.72% |
216,450
-9,500
| -4% | -$38.6K |
|
|
SRXH
48
SRX Global
SRXH
$26.7M
| $626K | 0.7% |
402
-29
| -7% | -$103K |
|
49
Verizon
VZ
$195B
| $623K | 0.7% |
16,417
-1,000
| -6% | -$44.5K |
|
50
AT&T
T
$160B
| $602K | 0.67% |
39,242
-2,295
| -6% | -$41.8K |
|
Similar funds
PWP
BF
SFG
HWMG
FTEA
WT
BAM
WLG
Perkins Capital Management's Q3 2022 Portfolio in Review
As of Q3 2022, Perkins Capital Management held 112 positions worth $89.4M, down 7.5% from $96.6M the previous quarter. Its ten largest holdings account for 35% of the portfolio.
Perkins Capital Management's Q3 2022 filing shows 7 new, 13 increased, 63 reduced and 8 closed positions. Its largest new stake was LeMaitre Vascular: 38,900 shares worth $1.97M. The largest sale was Sharps Compliance Corp, an estimated $552K.
By sector, the portfolio is most concentrated in Healthcare at 57% of assets, up from 54% a quarter earlier, followed by Technology and Communication Services.
- Perkins Capital Management's largest Q3 2022 buy was LeMaitre Vascular: 38,900 shares worth $1.97M.
- Perkins Capital Management added most to UpHealth, Inc. in Q3 2022, an estimated $171K increase.
- Perkins Capital Management's biggest Q3 2022 reduction was Digi International, cutting an estimated $199K.
- Perkins Capital Management fully exited Sharps Compliance Corp in Q3 2022, selling an estimated $552K.
- Perkins Capital Management's ten largest holdings make up 35% of its $89.4M portfolio in Q3 2022.
- Perkins Capital Management opened 7 new positions and closed 8 in Q3 2022.
- Perkins Capital Management's portfolio value fell 7.5% quarter-over-quarter to $89.4M.
Based on Perkins Capital Management's 13F filing for Q3 2022, filed 24 Oct 2022.